keep SUPPLEMENTARY LICENCE CONDITIONS: HUMAN APPLICATION
These Regulations implement EU Directives 2004/23/EC, 2006/17/EC, and 2006/86/EC into UK law, establishing quality and safety standards for the donation, procurement, testing, processing, preservation, storage, and distribution of human gametes and embryos. They amend the Human Fertilisation and Embryology Act 1990 by adding definitions, third party agreement requirements, traceability and adverse event reporting obligations, and licensing conditions for fertility services including non-medical fertility services. The regulations designate the HFEA as the competent authority for cross-border tissue exchange with EEA states.
While post-Brexit regulatory independence is valuable, wholesale deletion would remove essential safety mechanisms without which Britons would be worse off: traceability requirements prevent devastating gamete/embryo mix-ups that could destroy families; serious adverse event reporting enables rapid response to unsafe practices; and the licensing and inspection regime (predating these regulations in the 1990 Act) ensures clinics meet minimum competence standards. The core patient protection mechanisms here are not EU bureaucratic burdens but legitimate safety requirements that Adam Smith's heirs would recognise as protecting life and enabling trust in medical services. The limited scope for reform lies in streamlining compliance processes and removing any gold-plating, not in eliminating safety oversight of reproductive tissue entirely.